COMPARISON OF THE CELLULAR PHARMACOLOGY OF DOXORUBICIN IN RESISTANT AND SENSITIVE MODELS OF PANCREATIC-CANCER

被引：14

作者：

CHANG, BK ^{[1
]}

GREGORY, JA ^{[1
]}

机构：

[1] VET ADM MED CTR,MED RES SERV,AUGUSTA,GA 30904

来源：

关键词：

D O I：

10.1007/BF00434351

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：132 / 134

页数：3

共 22 条

[1]

Alberts DS, 1980, CLONING HUMAN TUMOR, P351

[2]

BACHUR NR, 1970, CANCER CHEMOTH REP 1, V54, P89

[3]

BACHUR NR, 1975, CANCER CHEMOTH REP 3, V6, P153

[4]

BENJAMIN RS, 1973, CLIN PHARMACOL THER, V14, P592

[5]

CHANG BK, 1982, CANCER RES, V42, P2666

[6]

CHANG BK, 1983, CANCER TREAT REP, V67, P355

[7]

CHERVINSKY DS, 1976, J MED, V7, P63

[8]

CORBETT TH, 1984, CANCER RES, V44, P717

DONELLI, MG ;

BARBIERI, B ;

ERBA, E ;

PACCIARINI, MA ;

SALMONA, A ;

GARATTINI, S ;

MORASCA, L .

[10]

GANAPATHI R, 1982, J NATL CANCER I, V68, P1027